SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sequana
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (253)9/25/1997 5:17:00 PM
From: Pseudo Biologist   of 337
 
Andrew, an amusing aside involving the NXTR mountain man. The current issue of Nature Biotechnology includes an exchange between Sequana scientists and a couple of NexStar people (one of whom is Dr. Gold). Gold and Alper wrote a letter in the April issue promoting the use of SELEX and/or antisense as a method to validate therapeutic targets obtained from genomic work; they titled their work "Keeping pace with genomics through combinatorial chemistry." Harris and Buckler from Sequana took issue with a couple of points, and Gold-Alper argued back. This is all pretty nerdy stuff except the punch line by Gold in which he borrows one of the sentences in the Sequana letter and <<requested that his gravestone be marked with the unintended praise from the Harris/Buclker letter, "His intellect was revealing in its naivete'.">> Now, I am sure we can borrow this sentence or something similar for arguments with biowa, squetch, etc.

And, yes, SQNA will go up another buck tomorrow -g-

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News